Home
Company
  • About Us
  • Vision & Mission
  • History
  • Management Board
  • Supervisory Board
  • Advisory Board
  • Contact Us
Pipeline
  • Biosimilars
  • Biosimilar Pipeline
  • FYB201
  • FYB202
  • FYB203
  • FYB206
Investors
  • Shares
  • Facts & Figures
  • Calendar
  • Financial Reports
  • Annual General Meeting 2024
  • Corporate Governance
  • Ad Hoc Announcements
  • News Distributor
News
  • Press Releases
  • Archive
Careers
  • Why Formycon
  • Your Benefits
  • Job Offers
DE EN
Loading...

Archives Publications

Half-Year-Report 2024

Half-Year-Report 2024

by Formycon AG

Annual Report 2023

Annual Report 2023

by Formycon AG

Half-Year-Report 2023

Half-Year-Report 2023

Half-Year-Report 2023

by Formycon AG

Annual Report 2022

Annual Report 2022

by Formycon AG

Half-Year-Report 2022

Half-Year-Report 2022

by Formycon AG

Annual Report 2021

Annual Report 2021

by Formycon AG

Half-Year-Report 2021

Half-Year-Report 2021

by Formycon AG

Annual Report 2020

Annual Report 2020

by Formycon AG

Half-Year-Report 2020

Half-Year-Report 2020

by Formycon AG

Annual Report 2019

Annual Report 2019

by Formycon AG

  • 1
  • 2
  • 3
Company
About Us Vision & Mission History Management Board Supervisory Board Advisory Board
News
Press Releases Downloads
Pipeline
Biosimilars Biosimilar Pipeline FYB201 FYB202 FYB203 FYB206
Career
Why Formycon Your Benefits Job Offers
Investors
Shares Facts & Figures News Distributor Financial Reports Calendar Annual General Meeting Corporate Governance Ad Hoc Announcements
Contact
Location & Approach Contact Persons
Social
Twitter XING LinkedIn
Member of Bio Deutschland Member of Medicines for Europe Member of UN Global Compact
Formycon AG
The Biosimilar Experts

© Formycon AG

Legal Notice Data Protection